Brian M Olson

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. pmc The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer
    Brian M Olson
    University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA
    Cancer Immunol Immunother 62:585-96. 2013
  2. pmc DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer
    Jordan T Becker
    Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI 53705, USA
    J Immunother 33:639-47. 2010
  3. pmc HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
    Brian M Olson
    Department of Medicine, University of Wisconsin, Madison, WI 53792, USA
    Cancer Immunol Immunother 59:943-53. 2010
  4. pmc Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade
    Brian M Olson
    University of Wisconsin Carbone Cancer Center, Madison, WI 53705, USA
    J Immunol 189:5590-601. 2012
  5. pmc CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells
    Brian M Olson
    Department of Medicine, University of Wisconsin, Madison, WI 53792, USA
    Cancer Immunol Immunother 60:781-92. 2011
  6. ncbi request reprint Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer
    Brian M Olson
    Department of Oncology, University of Wisconsin Madison, Madison, Wisconsin, USA
    Prostate 67:1729-39. 2007
  7. pmc Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
    Brian M Olson
    University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA
    Expert Rev Vaccines 11:1315-7. 2012
  8. pmc Vaccination using peptides spanning the SYT-SSX tumor-specific translocation
    Jordan E Bloom
    University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA
    Expert Rev Vaccines 11:1401-4. 2012

Collaborators

  • Douglas G McNeel
  • Jordan E Bloom
  • Jordan T Becker
  • Laura E Johnson
  • James G Davies
  • Edward J Dunphy

Detail Information

Publications8

  1. pmc The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer
    Brian M Olson
    University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA
    Cancer Immunol Immunother 62:585-96. 2013
    ..These data show that the AR is as a prostate cancer immunological target antigen and that a DNA vaccine targeting the AR LBD is an attractive candidate for clinical evaluation...
  2. pmc DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer
    Jordan T Becker
    Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI 53705, USA
    J Immunother 33:639-47. 2010
    ..Moreover, these results suggest that DNA vaccines targeting PAP could potentially be combined in heterologous immunization strategies with other vaccines to further augment PAP-specific T-cell immunity...
  3. pmc HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
    Brian M Olson
    Department of Medicine, University of Wisconsin, Madison, WI 53792, USA
    Cancer Immunol Immunother 59:943-53. 2010
    ..In addition, we propose that the epitopes identified here could be used to monitor immune responses in HLA-A2+ patients receiving vaccines targeting PAP to identify potentially therapeutic immune responses...
  4. pmc Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade
    Brian M Olson
    University of Wisconsin Carbone Cancer Center, Madison, WI 53705, USA
    J Immunol 189:5590-601. 2012
    ....
  5. pmc CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells
    Brian M Olson
    Department of Medicine, University of Wisconsin, Madison, WI 53792, USA
    Cancer Immunol Immunother 60:781-92. 2011
    ..These findings suggest that it may be possible to elicit an anti-prostate tumor immune response by augmenting CTL populations using AR LBD-based vaccines...
  6. ncbi request reprint Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer
    Brian M Olson
    Department of Oncology, University of Wisconsin Madison, Madison, Wisconsin, USA
    Prostate 67:1729-39. 2007
    ..In this report, we evaluated whether patients with prostate cancer have pre-existing immune responses specific for the AR as evidence that the AR also might be pursued as an immunological target antigen...
  7. pmc Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
    Brian M Olson
    University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA
    Expert Rev Vaccines 11:1315-7. 2012
    ....
  8. pmc Vaccination using peptides spanning the SYT-SSX tumor-specific translocation
    Jordan E Bloom
    University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA
    Expert Rev Vaccines 11:1401-4. 2012
    ....